- Drug discovery
- Personalized Medicine
- Our technology
- Your benefits
- About us
Over the last decade, high-throughput screening assays have produced thousands of candidate drugs with potential efficacy in pharmacological activity. However, a majority of these drugs have failed during drug development for reasons related to toxicity.
INOVOTION’s technology is a strong tool for evaluating the potential in vivo toxicity of your candidate drugs and their capacity to disturb the development of the embryo. INOVOTION has set up specific protocols to analyze and identify the toxicity of your drugs. During a standard toxicity assay, we follow the impact of your compounds on:
A standard Assay at INOVOTION:
Contact us for further information.